These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The 68 Ga-DOTA-FAPI-04 PET/CT for the differential diagnosis of solitary fibroma of pleura from other chest disease with low uptake of 18 F-FDG. Zhang A; Meng X; Zhou X; Wang S; Zhang Y; Li N Nucl Med Commun; 2022 Aug; 43(8):908-915. PubMed ID: 35551166 [TBL] [Abstract][Full Text] [Related]
26. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675 [TBL] [Abstract][Full Text] [Related]
27. A head-to-head comparison of Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the Relative Diagnostic Performance of [ Wu J; Wang Y; Liao T; Rao Z; Gong W; Ou L; Chen Y; Zhang C Front Oncol; 2021; 11():737827. PubMed ID: 34604078 [TBL] [Abstract][Full Text] [Related]
29. Biodistribution, pharmacokinetics, dosimetry of [ Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617 [TBL] [Abstract][Full Text] [Related]
30. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [ Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149 [TBL] [Abstract][Full Text] [Related]
31. [ Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma. Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422 [TBL] [Abstract][Full Text] [Related]
34. Comparison of Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976 [TBL] [Abstract][Full Text] [Related]
35. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types. Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165 [TBL] [Abstract][Full Text] [Related]
37. One-stop [ Liu G; Mao W; Yu H; Hu Y; Gu J; Shi H Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2271-2281. PubMed ID: 36971806 [TBL] [Abstract][Full Text] [Related]
38. Comparison of [ Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193 [TBL] [Abstract][Full Text] [Related]
39. Role of [ Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Diagnostic Efficacy of [ Zhang S; Wang W; Xu T; Ding H; Li Y; Liu H; Huang Y; Liu L; Du T; Zhao Y; Chen Y; Qiu L Front Oncol; 2022; 12():925100. PubMed ID: 35847877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]